Page last updated: 2024-11-03

rabeprazole and Ischemic Stroke

rabeprazole has been researched along with Ischemic Stroke in 1 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Ischemic Stroke: Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Usman, H1
Tan, Z1
Gul, M1
Rashid, S1
Ali, T1
Shah, FA1
Li, S1
Li, JB1

Other Studies

1 other study available for rabeprazole and Ischemic Stroke

ArticleYear
Identification of novel and potential PPARĪ³ stimulators as repurposed drugs for MCAO associated brain degeneration.
    Toxicology and applied pharmacology, 2022, 07-01, Volume: 446

    Topics: Animals; Brain; Brain Ischemia; Ethambutol; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mol

2022